Press Releases Press Releases Year None202020192018 Date Title September 11, 2020 InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference April 17, 2020 InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules April 15, 2020 InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules March 11, 2020 InVivo Therapeutics Announces Closing of $7.0 Million Public Offering March 6, 2020 InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering February 3, 2020 InVivo Therapeutics Announces Reverse Stock Split Invivo - Investor Tools Print Page Email Alerts RSS Feeds Contact IR
Press Releases Year None202020192018 Date Title September 11, 2020 InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference April 17, 2020 InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules April 15, 2020 InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules March 11, 2020 InVivo Therapeutics Announces Closing of $7.0 Million Public Offering March 6, 2020 InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering February 3, 2020 InVivo Therapeutics Announces Reverse Stock Split
